Earnings History Data for Bolt Biotherapeutics (BOLT) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Bolt Biotherapeutics

Bolt Biotherapeutics Inc. is a clinical-stage immuno-oncology company. It engages in the discovery, development, and commercialization of pharmaceutical products. The company's principal product includes BDC-1001. Bolt Biotherapeutics Inc. is based in Redwood city, California.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
12-11-2024	AH		BOLT	Bolt Biotherapeutics	25.00	-0.40	-0.36	0.00	Bolt Biotherapeutics GAAP EPS of -$0.40, revenue of $1.14M [11/13/2024 12:41 PM]	0.6260	-0.02 (-2.46%)	0.65	0.01 (1.96%)	0.55 - 1.56	98,909	70,000	21,015
Bolt Biotherapeutics GAAP EPS of -$0.40, revenue of $1.14M [11/13/2024 12:41 PM] Bolt Biotherapeutics reports Q3 results [11/13/2024 12:52 PM] Bolt Biotherapeutics Inc.: Q3 Earnings Snapshot [2024-11-12 04:27PM] Bolt Biotherapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update [2024-11-12 04:05PM] Bolt Biotherapeutics, Inc. (BOLT) Reports Q3 Loss, Tops Revenue Estimates [2024-11-12 05:35PM]
14-05-2024	AH		BOLT	Bolt Biotherapeutics	48.00	-0.28	-0.51	0.00	Bolt Biotherapeutics GAAP EPS of -$0.28, revenue of $5.3M [5/15/2024 10:19 AM]	0.8297	-0.49 (-37.14%)	1.00	-0.32 (-24.24%)	0.83 - 2.03	3,075,063	130,000	536,267
Bolt Biotherapeutics draws downgrades after portfolio shakeup [5/15/2024 8:33 AM] Bolt Biotherapeutics GAAP EPS of -$0.28, revenue of $5.3M [5/15/2024 10:19 AM]
21-03-2024	AH		BOLT	Bolt Biotherapeutics	44.00	-0.47	-0.47	0.00	Bolt Biotherapeutics GAAP EPS of -$0.47 in-line, revenue of $2.1M beats by $0.31M [3/21/2024 4:54 PM]	1.17	0.01 (1.07%)	1.20	0.04 (3.45%)	0.84 - 2.03	83,272	150,000	150
Bolt Biotherapeutics GAAP EPS of -$0.47 in-line, revenue of $2.1M beats by $0.31M [3/21/2024 4:54 PM]
07-08-2023	AH		BOLT	Bolt Biotherapeutics	50.00	-0.48	-0.53	0.00	Bolt Biotherapeutics GAAP EPS of -$0.48 misses by $0.01, revenue of $1.43M misses by $0.37M [8/7/2023 5:34 PM]	1.30	0.01 (0.78%)	1.29	0.0 (0.00%)	1.18 - 2.63	42,822	80,000	1,935
Bolt Biotherapeutics GAAP EPS of -$0.48 misses by $0.01, revenue of $1.43M misses by $0.37M [8/7/2023 5:34 PM]
10-11-2022	AH		BOLT	Bolt Biotherapeutics	49.00	-0.58	-0.56	0.00	Bolt Biotherapeutics GAAP EPS of -$0.58 misses by $0.01, revenue of $2.1M beats by $0.87M [11/10/2022 5:13 PM]	1.31	0.02 (1.55%)	0.0	0.0 (0.00%)	1.25 - 10.74	227,717	120,000	0
Bolt Biotherapeutics GAAP EPS of -$0.58 misses by $0.01, revenue of $2.1M beats by $0.87M [11/10/2022 5:13 PM] Bolt Biotherapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update [Nov-10-22 04:05PM]
10-08-2022	AH	4:05 PM ET (Aug 10)	BOLT	Bolt Biotherapeutics	87.00	-0.61	-0.68	0.00	Bolt Biotherapeutics GAAP EPS of -$0.61 beats by $0.08, revenue of $1.39M beats by $0.89M [8/10/2022 4:57 PM]	2.34	-0.18 (-7.14%)	2.38	-0.14 (-5.56%)	1.39 - 19.29	162,780	100,000	840
Bolt Biotherapeutics GAAP EPS of -$0.61 beats by $0.08, revenue of $1.39M beats by $0.89M [8/10/2022 4:57 PM] Bolt Biotherapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update [Aug-10-22 04:05PM]
09-11-2021	PM		BOLT	Bolt Biotherapeutics	442.00	-0.63	-0.63	0.00	Bolt Biotherapeutics EPS beats by $0.02, beats on revenue [11/9/2021 4:41 AM]	10.85	-0.87 (-7.42%)	0.0	0.0 (0.00%)	10.75 - 43.07	141,702	110,000	0
Bolt Biotherapeutics EPS beats by $0.02, beats on revenue [11/9/2021 4:41 AM] Bolt Biotherapeutics Reports Third Quarter 2021 Financial Results and Provides Business Highlights [Nov-09-21 04:05AM] Bolt Biotherapeutics to Present at Stifel 2021 Virtual Healthcare Conference [Nov-08-21 08:00AM]
13-05-2021	AH	4:05 PM ET (May 13)	BOLT	Bolt Biotherapeutics, Inc.	725.00	-0.86	-0.64	0.00	Bolt Biotherapeutics reports Q1 results [5/13/2021 5:27 PM]	18.81	0.48 (2.62%)	18.33	0.0 (0.00%)	17.30 - 43.07	673,332	130,000	6,407
Bolt Biotherapeutics reports Q1 results [5/13/2021 5:27 PM] Bolt Biotherapeutics Reports First Quarter 2021 Financial Results and Provides Business Highlights [May-13-21 04:05PM]